A fluorescence in situ hybridization (FISH) microfluidic platform for detection of HER2 amplification in cancer cells.

Explore this paper's citation graph

Summary

The microfluidic system developed herein is promising for rapid, automatic diagnosis of HER2-related diseases by detecting the HER2 gene with minimal consumption of samples and reagents and has a great potential for future pharmacogenetic diagnostics and therapy.

Type
article
Published
2015-07-15
Cited by
36
References
29

Keywords

Fluorescence in situ hybridization, In situ hybridization, Biomarker, Cancer, Fish

References

Cited by

Related papers